It is not a replacement for primary GLP-1 therapies, but rather an adjunct to optimise results across all stages of treatment
Individual responses to nutrition, lifestyle changes, bariatric surgery, and GLP-1 therapies can vary
When you take semaglutide, it targets several key areas to support weight loss: Appetite Regulation: It sends signals to the brainspecifically the hypothalamusto increase feelings of fullness and reduce hunger signals
Short-acting GLP-1 receptor agonists Short-acting GLP-1 agonists stay in your body for up to a day, so theyre typically taken once or twice a day (Hinnen, 2017)
Free Case Evaluation or call (205) 328-9200
The Centers for Medicare & Medicaid Services delayed another GLP-focused model following skepticism from insurers